Biosimilars Toolkit

The Biosimilars Council is committed to providing the best educational resources available on biosimilars. For your convenience, our team has built a Biosimilars Toolkit for your outreach efforts.

This toolkit contains a host of resources by the Biosimilars Council and its partners. These shareable resources explain what biosimilars are, why they are important, how they can improve patient access and how they can save the United States billions of dollars.

We encourage you to share this information on biosimilars with interested colleagues, individuals and organizations.

Top Biosimilars Resources

View the top resources on biosimilars, created and published by the Biosimilars Council.

Biosimilars Handbook

The Biosimilars Handbook is the premier resource for biosimilar education. Choose from four different tracks – medical professional, patient, insurer or policymaker – to learn how biosimilars and interchangeable biologic products can decrease costs and increase access to lifesaving medicines.

Read More

Biosimilars 101

Biosimilars, a more cost-effective option for many patients who rely on biologic treatments, are beginning to enter the market.

Read More

2018 Savings & Access Report

This 10th annual release is produced by the IQVIA Institute for Human Data Science, the standard bearer for measuring data, pharmaceutical use and spending in the United States.

Read More

Biosimilars in the United States: Providing More Patients Greater Access to Lifesaving Medicines

An analysis by Avalere Health for the Biosimilars Council finds that 1.2 million U.S. patients could gain access to biologics by 2025 as the result of biosimilar availability.

Read More

Interchangability 101 – Biosimilars and Interchangeable Biologics

This white board video from the Biosimilars Council walks through the basics of interchangeablity and why biosimilars and interchangeable biologics are more than acceptable replacements for brand biologics.

Watch Video

Fact Sheets, Infographics, and Video

View the top fact sheets, infographics and videos from the Biosimilars Council.

Fact Sheet
Biosimilars: A Safe & Effective Option for Patients

Fact Sheet
Biosimilars: Breaking Down Barriers to Patient Access

Infographic
Skyrocketing Drug Prices

Infographic
How a Biosimilar Reaches a Patient

Infographic
FDA Biosimilar Basics

Infographic
What is a Biosimilar?

Video
FDA Biosimilars Action Plan

Video
IGBA Biosimilars Video

Additional Resources by Stakeholder

Are you a patient, payer, medical professional or policymaker? Our team has curated content specifically for those requiring the most information on biosimilars. Choose a set of resources below, grouped by stakeholder.

For Patients

Infographic
Myths vs. Facts for Patients

Partner Resource
APhA’s Biosimilar Basics Pamphlet

Infographic
Breaking Down Barriers to Patient Access

Infographic
Biosimilars: A Safe & Effective Option for Patients

Partner Resource
Understanding Biologic and Biosimilar Drugs

Partner Resource
FDA Biosimilar Basics for Patients

For Payers

Infographic
Myths vs. Facts for Payers

Video
“Epic Opportunities” Panel Discussion with Industry Leaders

Partner Resource
Understanding Biologic and Biosimilar Drugs

Council Handbook
The New Frontier for Improved Access to Medicines

Whitepaper
Insulin Biosimilars

For Medical Professionals

Infographic
Myth vs. Facts for Medical Professionals

Partner Resource
Understanding Biologic and Biosimilar Drugs

Partner Resource
FDA Resources for Medical Professionals

Partner Resource
APhA’s Biosimilar Basics Pamphlet

Whitepaper
Insulin Biosimilars

For Policymakers

Infographic
Myth vs. Facts for Medical Policymakers

Video
Time to Pass the CREATES Act

Whitepaper
Breaking Through On Biosimilars

Partner Resource
Understanding Biologic and Biosimilar Drugs

Video
The Case for Generic Competition

Want to Get Social?

Feel free to use the below sample social media posts to share information on biosimilars or the Biosimilars Council.

Sample Twitter Posts:

  • #Biosmilars are safe, effective and increase patient access to essential medicines. Check out the @BiosimsCouncil Handbook to learn more: http://bit.ly/biosimshandbook
  • #Biosimilars could save the U.S. health care system over $250 billion in the next decade. Learn more with the @BiosimsCouncil: www.biosimilarscouncil.org
  • Take a deep dive into all things #biosimilars with @BiosimsCouncil Handbook: http://bit.ly/biosimshandbook

Sample Facebook Posts:

  • Biosimilars are safe, effective and increase patient access to essential medicines. Learn more at www.biosimilarscouncil.org
  • Biosimilars could save the U.S. health care system over $250 billion in the next decade. Learn more from the Biosimilars Handbook: http://bit.ly/biosimshandbook
  • New biosimilars could produce major cost savings for patients and the health care system. Learn more from the Biosimilars Handbook: http://bit.ly/biosimshandbook

Sample LinkedIn Posts:

  • Biosimilars have comparative safety and efficacy as their biologic counterpart, at a lower cost to the patient. Learn more about the benefits of biosimilars from our handbook: http://bit.ly/biosimshandbook
  • High standards for approval by the FDA ensure that patients and health care providers can rely on biosimilars when they go to market. Learn more about the approval process in our handbook: http://bit.ly/biosimshandbook
  • The introduction of safe and effective biosimilar therapies into the markets around the world has been proven to reduce health care costs while at the same time delivering lifesaving treatments to patients in need. https://biosimilarscouncil.org

Stay in the Loop

Stay up to date on the latest information and developments in the biosimilars industry by following us on social media or signing up for our newsletter.

Follow Us on Social Media

Be sure to follow the Biosimilars Council on Twitter, Facebook and LinkedIn to stay up to date on the latest news and information.

Suggest a New Resource

Do you have a suggestion or recommendation for a resource?

Sign Up for Our Monthly Newsletter

The Biosimilars Bulletin is our monthly newsletter round up of all new resources, articles and information from the last month.

Sign Up for Our Monthly Newsletter

The Biosimilars Bulletin is our monthly newsletter round up of all new resources, articles, and information from the last month.

Want to keep up to date with the biosimilars industry?

Sign up for Biosimilars Council Newsletter to hear about the field, learn about events, and find out how you can make an impact.

SIGN UP FOR OUR NEWSLETTER